Kolexia
Fischbach Michel Pédiatrie
Fischbach Michel
Pédiatrie
Hôpital Hautepierre
Strasbourg, France
132 Activités
0 Followers
Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Défaillance rénale chronique Arthrite Maladies du rein Insuffisance rénale chronique Arthrite juvénile Insuffisance rénale Syndrome d'activation macrophagique Hypertension artérielle Dermatomyosite

Collaborateurs

Voir plus
Zaloszyc Ariane
Zaloszyc Ariane
Hôpital Hautepierre, Strasbourg, France
Ranchin Bruno
Ranchin Bruno
Hôpital Femme Mère Enfant, Bron, France
Hankard Regis
Hankard Regis
Centre hospitalier de Tours, Tours, France
Piloquet Hugues
Piloquet Hugues
Hôpital Hôtel-Dieu Nantes, Nantes, France

Industries

Voir plus
INC RESEARCH, LLC
1 collaboration(s)
Dernière en 2018
{{person.topindus2.name}}
{{person.topindus2.tot}} collaboration(s)
Dernière en {{person.topindus2.last}}
{{person.topindus3.name}}
{{person.topindus3.tot}} collaboration(s)
Dernière en {{person.topindus3.last}}
{{person.topindus4.name}}
{{person.topindus4.tot}} collaboration(s)
Dernière en {{person.topindus4.last}}

Dernières activités

Voir plus
Abatacept as Monotherapy and in Combination With Methotrexate in Patients With Juvenile Idiopathic Arthritis: Analysis of 2 Phase III Trials.
The Journal of rheumatology   15 juillet 2023
Pharmacokinetics, Efficacy and Safety of Abatacept Administered Subcutaneously (SC) in Children and Adolescents With Active Polyarticular Juvenile Idiopathic Arthritis (pJIA) and Inadequate Response (IR) to Biologic or Non Biologic Disease Modifying Anti-rheumatic Drugs (DMARDs): A Phase 3 Multi-center, Open-Label Study to Evaluate Pharmacokinetics, Efficacy and Safety of Abatacept Administered Subcutaneously (SC) in Children and Adolescents With Active Polyarticular Juvenile Idiopathic Arthritis (pJIA) and Inadequate Response (IR) to Biologic or Non Biologic Disease Modifying Anti-rheumatic Drugs (DMARDs)
Essai Clinique (BMS)   26 juin 2023
PRINTOJDMTR: Five-year Single-blind, Phase III Effectiveness Randomised Actively Controlled Clinical Trial in New Onset Juvenile Dermatomyositis: Prednisone Versus Prednisone Plus Cyclosporine a Versus Prednisone Plus Methotrexate
Essai Clinique (Istituto Giannina Gaslini)   24 mars 2023
Nutritional and Anthropometric Indices in Children Receiving Haemodiafiltration vs Conventional Haemodialysis - The HDF, Heart and Height (3H) Study.
Journal of renal nutrition : the official journal of the Council on Renal Nutrition of the National Kidney Foundation   21 juillet 2022
Inactivation of Osteoblast PKC Signaling Reduces Cortical Bone Mass and Density and Aggravates Renal Osteodystrophy in Mice with Chronic Kidney Disease on High Phosphate Diet.
International journal of molecular sciences   08 juin 2022
Influenza and pneumococcus vaccination rates in pediatric dialysis patients in Europe: recommendations vs reality A European Pediatric Dialysis Working Group and European Society for Pediatric Nephrology Dialysis Working Group study.
Turkish journal of medical sciences   13 décembre 2021
Frequent, quantitative bone planar scintigraphy for determination of bone anabolism in growing mice.
PeerJ   09 décembre 2021
Hemodiafiltration Is Associated With Reduced Inflammation and Increased Bone Formation Compared With Conventional Hemodialysis in Children: The HDF, Hearts and Heights (3H) Study.
Kidney international reports   06 juillet 2021
Hemodiafiltration maintains a sustained improvement in blood pressure compared to conventional hemodialysis in children-the HDF, heart and height (3H) study.
Pediatric nephrology (Berlin, Germany)   24 février 2021
Haemodiafiltration does not lower protein-bound uraemic toxin levels compared with haemodialysis in a paediatric population.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association   26 octobre 2020